Opportunistic yeast infections, with special reference to candidiasis.
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D002175:Candida / Q000276:immunology; D002177:Candidiasis / Q000097:blood / Q000276:immunology / Q000382:microbiology; D002179:Candidiasis, Cutaneous / Q000209:etiology; D002180:Candidiasis, Oral / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D009092:Mucous Membrane / Q000382:microbiology
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents